Biotech & Pharma

Fifteenth In Vivo Lentiviral Vector-Based Therapeutic Technology Added to VIVEbiotech's CGT Platform

29 sec read5 views0 listens

VIVEbiotech has successfully added its fifteenth in vivo lentiviral vector-based therapeutic program to its cell and gene therapy (CGT) platform. These programs, designed for applications like in vivo CAR T and rare diseases, face more stringent quality requirements due to direct administration. This development highlights the increasing sophistication and challenges in gene therapy manufacturing, presenting opportunities for developers and tech professionals in process optimization, analytical characterization, and GMP facility expansion.

Read the full article at Genetic Engineering News

Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.

Organ-on-Chip Method Designed to Zero In on Connection Between Diabetes and Dementia

A University of Bath-led project, GlucoBrain, received £500,000 to develop an organ-on-chip device that replicates interactions between the brain, gut, and pancreas, aiming to uncover mechanisms linking diabetes with cognitive decline. This technolog...

Ali Nemati

Biotech & PharmaMay 1324 sec read

Synthesizing a Natural Sunscreen and Antioxidant in E. coli

Researchers at Jiangnan University have engineered E. coli to produce gadusol, a UV-protective compound with antioxidant properties, increasing yield by 93 times compared to natural extraction methods. This development offers a sustainable alternativ...

Ali Nemati

AI & Machine LearningMay 958 sec read

LSTM: Why It Was Born, How It Fixes RNN, and Why It Changed Sequence Learning

It all ties together beautifully, showing how the LSTM architecture addresses key challenges in sequence modeling and long-term dependency handling. Here's a concise summary of the main points: Cell State (Cₜ): Acts as an internal memory that accum...

Ali Nemati

AI & Machine LearningMay 929 sec read

The Co-Founder Vetting System Nobody Talks About (Until It's Too Late)

A robust system for finding and evaluating co-founders emphasizes pre-screening through former colleagues, domain-specific communities, and accelerator programs rather than casual meetups or online matching apps. This approach includes rigorous crite...

Ali Nemati

Education & EdTechMay 427 sec read

Five Things to Know About Largest Cell Phone Ban Study

A large-scale study reveals that school cell phone bans reduce distractions but do not significantly improve academic performance or behavior. This matters because it challenges the assumption that banning phones will quickly enhance educational outc...

Ali Nemati

Fifteenth In Vivo Lentiviral Vector-Based Therapeutic Technology Added to VIVEbiotech's CGT Platform

Related Articles

Organ-on-Chip Method Designed to Zero In on Connection Between Diabetes and Dementia

Synthesizing a Natural Sunscreen and Antioxidant in E. coli

LSTM: Why It Was Born, How It Fixes RNN, and Why It Changed Sequence Learning

The Co-Founder Vetting System Nobody Talks About (Until It's Too Late)

Five Things to Know About Largest Cell Phone Ban Study